Paganuzzi M - Search Results

1

Diagnostic value of CYFRA 21-1 tumor marker and CEA in pleural effusion due to mesothelioma.

Paganuzzi M, Onetto M, Marroni P, Filiberti R, Tassara E, Parodi S, Felletti R. Paganuzzi M, et al. Chest. 2001 Apr;119(4):1138-42. doi: 10.1378/chest.119.4.1138. Chest. 2001. PMID: 11296181

2

A bibliometric analysis of scientific production in mesothelioma research.

Ugolini D, Neri M, Casilli C, Ceppi M, Canessa PA, Ivaldi GP, Paganuzzi M, Bonassi S. Ugolini D, et al. Among authors: paganuzzi m. Lung Cancer. 2010 Nov;70(2):129-35. doi: 10.1016/j.lungcan.2010.01.013. Epub 2010 Feb 18. Lung Cancer. 2010. PMID: 20170978

3

Serum PDGF-AB in pleural mesothelioma.

Filiberti R, Marroni P, Neri M, Ardizzoni A, Betta PG, Cafferata MA, Canessa PA, Puntoni R, Ivaldi GP, Paganuzzi M. Filiberti R, et al. Among authors: paganuzzi m. Tumour Biol. 2005 Sep-Oct;26(5):221-6. doi: 10.1159/000087376. Epub 2005 Aug 9. Tumour Biol. 2005. PMID: 16103743

4

Osteopontin is not a specific marker in malignant pleural mesothelioma.

Paleari L, Rotolo N, Imperatori A, Puzone R, Sessa F, Franzi F, Meacci E, Camplese P, Cesario A, Paganuzzi M. Paleari L, et al. Among authors: paganuzzi m. Int J Biol Markers. 2009 Apr-Jun;24(2):112-7. doi: 10.5301/jbm.2009.5043. Int J Biol Markers. 2009. PMID: 19634115 Free article.

5

The CREST biorepository: a tool for molecular epidemiology and translational studies on malignant mesothelioma, lung cancer, and other respiratory tract diseases.

Ugolini D, Neri M, Canessa PA, Casilli C, Catrambone G, Ivaldi GP, Lando C, Marroni P, Paganuzzi M, Parodi B, Visconti P, Puntoni R, Bonassi S. Ugolini D, et al. Among authors: paganuzzi m. Cancer Epidemiol Biomarkers Prev. 2008 Nov;17(11):3013-9. doi: 10.1158/1055-9965.EPI-08-0524. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18990743

6

Clinical significance of serum mesothelin in patients with mesothelioma and lung cancer.

Cristaudo A, Foddis R, Vivaldi A, Guglielmi G, Dipalma N, Filiberti R, Neri M, Ceppi M, Paganuzzi M, Ivaldi GP, Mencoboni M, Canessa PA, Ambrosino N, Chella A, Mutti L, Puntoni R. Cristaudo A, et al. Among authors: paganuzzi m. Clin Cancer Res. 2007 Sep 1;13(17):5076-81. doi: 10.1158/1078-0432.CCR-07-0629. Clin Cancer Res. 2007. PMID: 17785560

7

Decline in serum carcinoembryonic antigen and cytokeratin 19 fragment during chemotherapy predicts objective response and survival in patients with advanced nonsmall cell lung cancer.

Ardizzoni A, Cafferata MA, Tiseo M, Filiberti R, Marroni P, Grossi F, Paganuzzi M. Ardizzoni A, et al. Among authors: paganuzzi m. Cancer. 2006 Dec 15;107(12):2842-9. doi: 10.1002/cncr.22330. Cancer. 2006. PMID: 17103443 Free article.

8

Prognostic role of serum sialyl Lewisx (CD15s) in colorectal cancer.

Paganuzzi M, Bobbio B, Marroni P, Filiberti R, Secco GB, Grossi CE. Paganuzzi M, et al. Oncology. 2003;65(1):52-9. doi: 10.1159/000071205. Oncology. 2003. PMID: 12837983

9

c-erbB-2 protein in serum of primary lung cancer patients.

Filiberti R, Marroni P, Paganuzzi M, Izzo V, Padovani P, Cafferata M, Ardizzoni A, Neri M, Raimondi L, Puntoni R. Filiberti R, et al. Among authors: paganuzzi m. Cancer Detect Prev. 2002;26(1):64-8. doi: 10.1016/s0361-090x(02)00014-4. Cancer Detect Prev. 2002. PMID: 12088205

10

Serum anti-p53 autoantibodies in pleural malignant mesothelioma, lung cancer and non-neoplastic lung diseases.

Neri M, Betta P, Marroni P, Filiberti R, Cafferata M, Mereu C, Ivaldi G, Montanaro F, Puntoni R, Paganuzzi M. Neri M, et al. Among authors: paganuzzi m. Lung Cancer. 2003 Feb;39(2):165-72. doi: 10.1016/s0169-5002(02)00449-x. Lung Cancer. 2003. PMID: 12581569

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results